TIDMAMS
RNS Number : 0347Y
Advanced Medical Solutions Grp PLC
30 November 2017
30 November 2017
Advanced Medical Solutions Group plc
("AMS", the "Company" or the "Group")
Director/PDMR Shareholding
Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), a
leading developer and manufacturer of advanced products for the
global surgical and advanced wound care markets, announces it was
notified on 27 November 2017 that Chris Meredith, who is a Director
and PDMR, following the end of the holding period, has exercised
22,203 options from the Deferred Annual Bonus Plan (DAB). Mr
Meredith elected to receive an additional 296 dividend shares which
were earned during the 3 year holding period under the terms of
this scheme. Mr Meredith subsequently sold 10,726 Ordinary Shares
of 5p each on 27 November 2017 at a share price of 312.109p per
Ordinary Share to cover the tax and National Insurance payable on
this exercise.
As a result of these transactions Chris Meredith's beneficial
interest in the Company has increased from 1,470,306 shares to
1,482,079 shares.
Deferred Annual Bonus Plan (DAB)
Director DABs DABs Dividend Ordinary Ordinary DABs
prior exercised Shares Shares Shares after
to exercise received sold retained exercise
----------------- ------------- ----------- ---------- --------- ---------- ----------
Chris Meredith,
Chief
Executive
Officer 105,587 22,203 296 10,726 11,773 83,384
----------------- ------------- ----------- ---------- --------- ---------- ----------
Overall Holding
Director Holding Number Dividend Number Sale Resultant % of
prior of shares Shares of shares price holding issued
to exercise exercised received sold (p) share
capital
----------------- ------------- ----------- ---------- ----------- --------- ---------- ---------
Chris Meredith,
Chief
Executive
Officer 1,470,306 22,203 296 10,726 312.109p 1,482,079 0.7%
----------------- ------------- ----------- ---------- ----------- --------- ---------- ---------
The Company further announces that it was notified on 27
November 2017 that Mary Tavener, who is a Director and PDMR,
following the end of the holding period, has exercised 17,207
options from the Deferred Annual Bonus Plan (DAB). Mrs Tavener
elected to receive an additional 229 dividend shares which were
earned during the 3 year holding period under the terms of the
scheme. Mrs Tavener subsequently sold 8,313 Ordinary Shares of 5p
each on 27 November 2017 at a share price of 312.109p per Ordinary
Share to cover the tax and National Insurance payable on this
exercise.
As a result of these transactions Mary Tavener's beneficial
interest in the Company has increased from 1,950,568 shares to
1,959,691 shares.
Deferred Annual Bonus Plan (DAB)
Director DABs DABs Dividend Ordinary Ordinary DABs
prior exercised Shares Shares Shares after
to exercise received sold retained exercise
------------------ ------------- ----------- ---------- --------- ---------- ----------
Mary Tavener,
Chief Financial
Officer 72,935 17,207 229 8,313 9,123 55,728
------------------ ------------- ----------- ---------- --------- ---------- ----------
Overall Holding
Director Holding Number Dividend Number Sale Resultant % of
prior of shares Shares of shares price holding issued
to exercise exercised received sold (p) share
capital
--------------- ------------- ----------- ---------- ----------- --------- ---------- ---------
Mary Tavener,
Chief
Financial
Officer 1,950,568 17,207 229 8,313 312.109p 1,959,691 0.92%
--------------- ------------- ----------- ---------- ----------- --------- ---------- ---------
The Company further announces that it was notified on 27
November 2017 that Eddie Johnson, who is a Senior Manager and PDMR,
following the successful achievement of certain performance
criteria, has exercised 38,450 options from the Long Term Incentive
Plan (LTIP). Mr Johnson has also, following the end of the holding
period, exercised 3,115 options from the Deferred Annual Bonus Plan
(DAB). Mr Johnson elected to receive an additional 41 dividend
shares which were earned during the 3 year holding period under the
terms of the scheme. Mr Johnson subsequently sold 41,606 Ordinary
Shares of 5p each on 27 November 2017 at a share price of 312.109p
per Ordinary Share. Following these transactions the beneficial
ownership of Eddie Johnson is as follows:
Long Term Incentive Plan (LTIP)
PDMR No. of LTIPs LTIPs Ordinary Ordinary LTIPs
LTIPs prior exercised lapsed Shares Shares after
to exercise sold retained exercise
--------------- ------------- ----------- -------- --------- ---------- ----------
Eddie Johnson 144,139 38,450 11,550 38,450 Nil 94,139
--------------- ------------- ----------- -------- --------- ---------- ----------
Deferred Annual Bonus Plan (DAB)
PDMR DABs DABs Dividend Ordinary Ordinary DABs
prior exercised Shares Shares Shares after
to exercise received sold retained exercise
--------------- ------------- ----------- ---------- --------- ---------- ----------
Eddie Johnson 19,359 3,115 41 3,156 Nil 16,244
--------------- ------------- ----------- ---------- --------- ---------- ----------
Overall Holding
PDMR Holding Number Dividend Number Sale Resultant % of
prior of shares Shares of shares price holding issued
to exercise exercised received sold (p) share
capital
--------------- ------------- ----------- ---------- ----------- --------- ---------- ---------
Eddie Johnson 48,734 41,565 41 41,606 312.109p 48,734 0.023%
--------------- ------------- ----------- ---------- ----------- --------- ---------- ---------
The Company further announces that it was notified on 27
November 2017 that Pieter van Hoof, who is a Senior Manager and
PDMR, following the successful achievement of certain performance
criteria, has exercised 38,450 options from the Long Term Incentive
Plan (LTIP). Mr van Hoof has also, following the end of the holding
period, exercised 2,993 options from the Deferred Annual Bonus Plan
(DAB). Mr van Hoof elected to receive an additional 39 dividend
shares which were earned during the 3 year holding period under the
terms of the scheme. Mr van Hoof has also elected to exercise
38,387 Ordinary Shares of 5p from the Deferred Share Bonus Plan
(DSB).
Mr van Hoof subsequently sold 32,810 Ordinary Shares of 5p each
on 27 November 2017 at a share price of 312.109p per Ordinary Share
to cover the tax and National Insurance payable on this exercise.
As a result of these transactions Pieter van Hoof's beneficial
interest in the Company has increased from 76,282 shares to 123,341
shares.
Long Term Incentive Plan (LTIP)
PDMR No. of LTIPs LTIPs Ordinary Ordinary LTIPs
LTIPs prior exercised lapsed Shares Shares after
to exercise sold retained exercise
------------ ------------- ----------- -------- --------- ---------- ----------
Pieter van
Hoof 144,933 38,450 11,550 15,802 22,648 94,933
------------ ------------- ----------- -------- --------- ---------- ----------
Deferred Annual Bonus Plan (DAB)
PDMR DABs DABs Dividend Ordinary Ordinary DABs
prior exercised Shares Shares Shares after
to exercise received sold retained exercise
------------ ------------- ----------- ---------- --------- ---------- ----------
Pieter van
Hoof 17,819 2,993 39 1,230 1,802 14,826
------------ ------------- ----------- ---------- --------- ---------- ----------
Deferred Share Bonus Plan (DSB)
PDMR No. of DSBs DSBs exercised Ordinary Ordinary DSBs after
prior to Shares Shares exercise
exercise sold retained
------------ ------------ --------------- --------- ---------- -----------
Pieter van
Hoof 60,057 38,387 15,778 22,609 21,670
------------ ------------ --------------- --------- ---------- -----------
Overall Holding
PDMR Holding Number Dividend Number Sale Resultant % of
prior of shares Shares of shares price holding issued
to exercise exercised received sold (p) share
capital
------------ ------------- ----------- ---------- ----------- --------- ---------- ---------
Pieter van
Hoof 76,282 79,830 39 32,810 312.109p 123,341 0.058%
------------ ------------- ----------- ---------- ----------- --------- ---------- ---------
The Company further announces that it was notified on 27
November 2017 that Jeff Willis, who is a Senior Manager and PDMR,
following the end of the holding period, has exercised 2,437
options from the Deferred Annual Bonus Plan (DAB). Mr Willis
elected to receive an additional 32 dividend shares which were
earned during the 3 year holding period under the terms of the
scheme. Mr Willis has also elected to exercise 5,617 Ordinary
Shares of 5p from the Deferred Share Bonus Plan (DSB). Mr Willis
subsequently sold 12,512 Ordinary Shares of 5p each on 27 November
2017 at a share price of 312.109p per Ordinary Share. As a result
of these transactions Jeff Willis's beneficial interest in the
Company has decreased from 165,765 shares to 161,339 shares.
Deferred Annual Bonus Plan (DAB)
PDMR DABs DABs Dividend Ordinary Ordinary DABs
prior exercised Shares Shares Shares after
to exercise received sold retained exercise
------------- ------------- ----------- ---------- --------- ---------- ----------
Jeff Willis 23,531 2,437 32 2,469 Nil 21,094
------------- ------------- ----------- ---------- --------- ---------- ----------
Deferred Share Bonus Plan (DSB)
PDMR No. of DSBs DSBs exercised Ordinary Ordinary DSBs after
prior to Shares Shares exercise
exercise sold retained
------------- ------------ --------------- --------- ---------- -----------
Jeff Willis 31,426 5,617 5,617 Nil 25,809
------------- ------------ --------------- --------- ---------- -----------
Overall Holding
PDMR Holding Number Dividend Number Sale Resultant % of
prior of shares Shares of shares price holding issued
to exercise exercised received sold (p) share
capital
------------- ------------- ----------- ---------- ----------- --------- ---------- ---------
Jeff Willis 165,765 8,054 32 12,512 312.109p 161,339 0.075%
------------- ------------- ----------- ---------- ----------- --------- ---------- ---------
The notification below, made in accordance with the requirements
of the EU Market Abuse Regulation, provides further detail.
Notification and public disclosure of transactions by persons
discharging managerial responsibilities and persons closely
associated with them
1. Details of the person discharging managerial
responsibilities/person closely associated
--- ----------------------------------------------------------------
a) Name: Chris Meredith
--- ----------------------------------------------------------------
2. Reason for the notification
--- ----------------------------------------------------------------
a) Position/status: Director/PDMR
--- ----------------------------------------------------------------
b) Initial notification/Amendment: Initial
Notification
--- ----------------------------------------------------------------
3. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
--- ----------------------------------------------------------------
a) Name: Advanced Medical Solutions Group
plc
--- ----------------------------------------------------------------
b) LEI: 213800HJP6OWOSZI1L74
--- ----------------------------------------------------------------
4. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
--- ----------------------------------------------------------------
a) Description of the financial instrument,
type of instrument: Ordinary Shares of
5p
Identification code: GB0004536594
--- ----------------------------------------------------------------
b) Nature of the transactions:
* Exercise of 22,203 shares from the Deferred Annual
Bonus Plan
* Award of 296 Dividend Shares from the Deferred Annual
Bonus Plan
* Sale of 10,726 Ordinary Shares of 5p
--- ----------------------------------------------------------------
c) Price(s) and volume(s):
Sale of shares: Price(s) Volume(s)
------------ ----------
GBP3.12109 10,726
------------ ----------
--- ----------------------------------------------------------------
d) Aggregated information: (Relates to those
shares sold only)
Aggregated volume: 10,726
Aggregated price: GBP3.12109
--- ----------------------------------------------------------------
e) Date of the transaction: 27/11/2017
--- ----------------------------------------------------------------
f) Place of the transaction: London Stock
Exchange, AIM Market (XLON)
--- ----------------------------------------------------------------
1. Details of the person discharging managerial
responsibilities/person closely associated
--- ----------------------------------------------------------------
a) Name: Mary Tavener
--- ----------------------------------------------------------------
2. Reason for the notification
--- ----------------------------------------------------------------
a) Position/status: Director/PDMR
--- ----------------------------------------------------------------
b) Initial notification/Amendment: Initial
Notification
--- ----------------------------------------------------------------
3. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
--- ----------------------------------------------------------------
a) Name: Advanced Medical Solutions Group
plc
--- ----------------------------------------------------------------
b) LEI: 213800HJP6OWOSZI1L74
--- ----------------------------------------------------------------
4. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
--- ----------------------------------------------------------------
a) Description of the financial instrument,
type of instrument: Ordinary Shares of
5p
Identification code: GB0004536594
--- ----------------------------------------------------------------
b) Nature of the transactions:
* Exercise of 17,207 shares from the Deferred Annual
Bonus Plan
* Award of 229 Dividend Shares from the Deferred Annual
Bonus Plan
* Sale of 8,313 Ordinary Shares of 5p
--- ----------------------------------------------------------------
c) Price(s) and volume(s):
Sale of shares: Price(s) Volume(s)
------------ ----------
GBP3.12109 8,313
------------ ----------
--- ----------------------------------------------------------------
d) Aggregated information: (Relates to those
shares sold only)
Aggregated volume: 8,313
Aggregated price: GBP3.12109
--- ----------------------------------------------------------------
e) Date of the transaction: 27/11/2017
--- ----------------------------------------------------------------
f) Place of the transaction: London Stock
Exchange, AIM Market (XLON)
--- ----------------------------------------------------------------
1. Details of the person discharging managerial
responsibilities/person closely associated
--- ---------------------------------------------------------------
a) Name: Eddie Johnson
--- ---------------------------------------------------------------
2. Reason for the notification
--- ---------------------------------------------------------------
a) Position/status: Senior Manager/PDMR
--- ---------------------------------------------------------------
b) Initial notification/Amendment: Initial
Notification
--- ---------------------------------------------------------------
3. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
--- ---------------------------------------------------------------
a) Name: Advanced Medical Solutions Group
plc
--- ---------------------------------------------------------------
b) LEI: 213800HJP6OWOSZI1L74
--- ---------------------------------------------------------------
4. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
--- ---------------------------------------------------------------
a) Description of the financial instrument,
type of instrument: Ordinary Shares of
5p
Identification code: GB0004536594
--- ---------------------------------------------------------------
b) Nature of the transaction:
* Exercise of 38,450 shares from the Long Term
Incentive Plan
* Exercise of 3,115 shares from the Deferred Annual
Bonus Plan
* Award of 41 Dividend Shares from the Deferred Annual
Bonus Plan
* Sale of 41,606 Ordinary Shares of 5p
--- ---------------------------------------------------------------
c) Price(s) and volume(s):
Sale of shares: Price(s) Volume(s)
------------ ----------
GBP3.12109 41,606
------------ ----------
--- ---------------------------------------------------------------
d) Aggregated information: (Relates to those
shares sold only)
Aggregated volume: 41,606
Aggregated price: GBP3.12109
--- ---------------------------------------------------------------
e) Date of the transaction: 27/11/2017
--- ---------------------------------------------------------------
f) Place of the transaction: London Stock
Exchange, AIM Market (XLON)
--- ---------------------------------------------------------------
1. Details of the person discharging managerial
responsibilities/person closely associated
--- ---------------------------------------------------------------
a) Name: Pieter van Hoof
--- ---------------------------------------------------------------
2. Reason for the notification
--- ---------------------------------------------------------------
a) Position/status: Senior Manager/PDMR
--- ---------------------------------------------------------------
b) Initial notification/Amendment: Initial
Notification
--- ---------------------------------------------------------------
3. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
--- ---------------------------------------------------------------
a) Name: Advanced Medical Solutions Group
plc
--- ---------------------------------------------------------------
b) LEI: 213800HJP6OWOSZI1L74
--- ---------------------------------------------------------------
4. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
--- ---------------------------------------------------------------
a) Description of the financial instrument,
type of instrument: Ordinary Shares of
5p
Identification code: GB0004536594
--- ---------------------------------------------------------------
b) Nature of the transactions:
* Exercise of 38,450 shares from the Long Term
Incentive Plan
* Exercise of 2,993 shares from the Deferred Annual
Bonus Plan
* Award of 39 Dividend Shares from the Deferred Annual
Bonus Plan
* Exercise of 38,387 shares from the Deferred Share
Bonus Plan
* Sale of 32,810 Ordinary Shares of 5p
--- ---------------------------------------------------------------
c) Price(s) and volume(s):
Sale of shares: Price(s) Volume(s)
------------ ----------
GBP3.12109 32,810
------------ ----------
--- ---------------------------------------------------------------
d) Aggregated information: (Relates to those
shares sold only)
Aggregated volume: 32,810
Aggregated price: GBP3.12109
--- ---------------------------------------------------------------
e) Date of the transaction: 27/11/2017
--- ---------------------------------------------------------------
f) Place of the transaction: London Stock
Exchange, AIM Market (XLON)
--- ---------------------------------------------------------------
1. Details of the person discharging managerial
responsibilities/person closely associated
--- ---------------------------------------------------------------
a) Name: Jeff Willis
--- ---------------------------------------------------------------
2. Reason for the notification
--- ---------------------------------------------------------------
a) Position/status: Senior Manager/PDMR
--- ---------------------------------------------------------------
b) Initial notification/Amendment: Initial
Notification
--- ---------------------------------------------------------------
3. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
--- ---------------------------------------------------------------
a) Name: Advanced Medical Solutions Group
plc
--- ---------------------------------------------------------------
b) LEI: 213800HJP6OWOSZI1L74
--- ---------------------------------------------------------------
4. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
--- ---------------------------------------------------------------
a) Description of the financial instrument,
type of instrument: Ordinary Shares of
5p
Identification code: GB0004536594
--- ---------------------------------------------------------------
b) Nature of the transactions:
* Exercise of 2,437 shares from the Deferred Annual
Bonus Plan
* Award of 32 Dividend Shares from the Deferred Annual
Bonus Plan
* Exercise of 5,617 shares from the Deferred Share
Bonus Plan
* Sale of 12,512 Ordinary Shares of 5p
--- ---------------------------------------------------------------
c) Price(s) and volume(s):
Sale of shares: Price(s) Volume(s)
------------ ----------
GBP3.12109 12,512
------------ ----------
--- ---------------------------------------------------------------
d) Aggregated information: (Relates to those
shares sold only)
Aggregated volume: 12,512
Aggregated price: GBP3.12109
--- ---------------------------------------------------------------
e) Date of the transaction: 27/11/2017
--- ---------------------------------------------------------------
f) Place of the transaction: London Stock
Exchange, AIM Market (XLON)
--- ---------------------------------------------------------------
-End -
For further information, please visit www.admedsol.com or
contact:
Advanced Medical Solutions Group Tel: +44 (0)
plc 1606 545508
Chris Meredith, Chief Executive
Officer
Mary Tavener, Chief Financial
Officer
Consilium Strategic Communications Tel: +44 (0)
20 3709 5700
Mary-Jane Elliott / Matthew Neal AMS@consilium-comms.com
/ Philippa Gardner / Rosie Phillips
Investec Bank PLC (NOMAD & Broker) Tel: +44 (0)
20 7597 5970
Daniel Adams / Gary Clarence
/ Patrick Robb
About Advanced Medical Solutions Group plc - see
www.admedsol.com
AMS is a world-leading independent developer and manufacturer of
innovative and technologically advanced products for the global
surgical, wound care and wound closure markets, focused on quality
outcomes for patients and value for payors. AMS has a wide range of
products that include silver alginates, alginates, foams, tissue
adhesives, sutures and haemostats, which it markets under its
brands; ActivHeal(R), LiquiBand(R) and RESORBA(R) as well as
supplying under white label.
AMS's products, manufactured out of two sites in the UK, one in
the Netherlands, two in Germany and one in the Czech Republic, are
sold in more than 75 countries via a network of multinational or
regional partners and distributors, as well as via AMS's own direct
sales forces in the UK, Germany, the Czech Republic and Russia.
Established in 1991, the Group has approximately 600 employees. For
more information, please see www.admedsol.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHBUBDBDUXBGRG
(END) Dow Jones Newswires
November 30, 2017 10:54 ET (15:54 GMT)
Advanced Medical Solutions (LSE:AMS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Advanced Medical Solutions (LSE:AMS)
Historical Stock Chart
From Apr 2023 to Apr 2024
